CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 84% of retail investor accounts lose money when trading CFDs with this provider. You should consider whether you understand how CFDs work and whether you can afford to take the high risk of losing your money.

Scan to Download iOS&Android APP

Trade CVS Health - CVS CFD

88.89
3.44%
0.27
Low: 88.48
High: 90.11
Market Trading Hours* (UTC) Opens on Thursday at 14:30

Mon - Fri: 14:30 - 21:00

  • Summary
  • Historical Data
  • Events
  • Income Statement
  • Balance Sheet
  • Cash Flow
  • Ownership
Trading Conditions
Spread 0.27
Long position overnight fee

Long position overnight fee


Margin. Your investment $1,000.00
Overnight fee -0.030779 %
Charges from borrowed part ($-1.23)
Trade size with leverage ~ $5,000.00
Money from leverage ~ $4,000.00

Go to platform
-0.030779%
Short position overnight fee

Short position overnight fee


Margin. Your investment $1,000.00
Overnight fee -0.013666 %
Charges from borrowed part ($-0.55)
Trade size with leverage ~ $5,000.00
Money from leverage ~ $4,000.00

Go to platform
-0.013666%
Overnight fee time 22:00 (UTC)
Min traded quantity 1
Currency USD
Margin 20%
Stock exchange United States of America
Commission on trade 0%

*Information provided by Capital.com

CVS Health Corp ESG Risk Ratings

High Medium Low Negligible

‘C’ score indicates satisfactory relative ESG performance and moderate degree of transparency in reporting material ESG data publicly.

More ESG coverage

Key Stats
Prev. Close* 85.93
Open* 88.48
1-Year Change* -19%
Day's Range* 88.48 - 90.11
52 wk Range 84.82-111.25
Average Volume (10 days) 10.08M
Average Volume (3 months) 147.94M
Market Cap 112.02B
P/E Ratio 36.23
Shares Outstanding 1.31B
Revenue 315.23B
EPS 2.35
Dividend (Yield %) 2.83871
Beta 0.62
Next Earnings Date Feb 8, 2023

All data is provided by Refinitiv, except for data marked with an asterisk, which is *data provided by Capital.com

  • Last Week
  • Last Month
  • Last Year
  • Last two Years
  • Max
  • Daily
  • Weekly
  • Monthly
Date Close Change Change (%) Open High Low
Feb 7, 2023 85.93 0.91 1.07% 85.02 86.56 84.44
Feb 6, 2023 85.18 -0.18 -0.21% 85.36 86.51 85.10
Feb 3, 2023 85.70 -0.79 -0.91% 86.49 87.52 85.52
Feb 2, 2023 86.07 -0.02 -0.02% 86.09 86.91 85.35
Feb 1, 2023 87.36 -0.55 -0.63% 87.91 88.10 86.53
Jan 31, 2023 88.09 1.24 1.43% 86.85 88.41 86.85
Jan 30, 2023 86.98 -0.82 -0.93% 87.80 88.29 86.91
Jan 27, 2023 87.68 0.03 0.03% 87.65 88.04 86.92
Jan 26, 2023 87.55 1.18 1.37% 86.37 87.69 85.95
Jan 25, 2023 85.68 0.63 0.74% 85.05 85.94 84.75
Jan 24, 2023 85.95 -0.47 -0.54% 86.42 86.91 85.84
Jan 23, 2023 87.13 0.28 0.32% 86.85 87.38 86.51
Jan 20, 2023 86.93 -0.41 -0.47% 87.34 87.41 86.69
Jan 19, 2023 87.40 0.27 0.31% 87.13 88.22 86.94
Jan 18, 2023 88.09 -1.36 -1.52% 89.45 89.64 87.96
Jan 17, 2023 89.26 -0.74 -0.82% 90.00 90.43 89.03
Jan 13, 2023 89.83 1.20 1.35% 88.63 90.33 88.45
Jan 12, 2023 89.11 -0.55 -0.61% 89.66 89.90 88.94
Jan 11, 2023 89.71 -1.87 -2.04% 91.58 91.58 89.29
Jan 10, 2023 90.56 0.31 0.34% 90.25 91.29 88.40

CVS Health Events

Time (UTC) Country Event
No events scheduled
View all events
  • Annual
  • Quarterly
2016 2017 2018 2019 2020 2021
Total revenue 177546 184786 194579 256776 268706 292111
Revenue 177546 184786 194579 256776 268706 292111
Cost of Revenue, Total 146533 153448 156447 158719 163981 175803
Gross Profit 31013 31338 38132 98057 104725 116308
Total Operating Expense 167803 175248 190558 244868 256235 279370
Selling/General/Admin. Expenses, Total 18448 18809 21368 396 461 523
Unusual Expense (Income) 643 181 6149 559 1503 2373
Other Operating Expenses, Total 2179 2810 6594 85194 90290 100671
Operating Income 9743 9538 4021 11908 12471 12741
Interest Income (Expense), Net Non-Operating -1078 -1062 -2619 -3035 -2907 -2503
Other, Net -28 -208 4 124 206 182
Net Income Before Taxes 8637 8268 1406 8997 9770 10420
Net Income After Taxes 5320 5131 -696 6631 7201 7898
Minority Interest -2 -1 2 3 -13 12
Net Income Before Extra. Items 5318 5130 -694 6634 7188 7910
Total Extraordinary Items -1 1492 100 0 -9 0
Net Income 5317 6622 -594 6634 7179 7910
Total Adjustments to Net Income -26 -16 -3 0 0
Income Available to Common Excl. Extra. Items 5292 5114 -697 6634 7188 7910
Income Available to Common Incl. Extra. Items 5291 6606 -597 6634 7179 7910
Diluted Net Income 5291 6606 -597 6634 7179 7910
Diluted Weighted Average Shares 1079 1024 1044 1305 1314 1329
Diluted EPS Excluding Extraordinary Items 4.90454 4.99414 -0.66762 5.08352 5.47032 5.95184
Dividends per Share - Common Stock Primary Issue 1.7 2 2 2 2 2
Diluted Normalized EPS 5.2716 5.10383 3.16078 5.51501 6.31339 7.27044
Q1 2021 Q2 2021 Q3 2021 Q4 2021 Q1 2022
Total revenue 69097 72616 73794 76604 76826
Revenue 69097 72616 73794 76604 76826
Cost of Revenue, Total 40894 43520 45011 46378 45509
Gross Profit 28203 29096 28783 30226 31317
Total Operating Expense 65520 68290 71096 74464 73336
Selling/General/Admin. Expenses, Total 8881 8829 9190
Unusual Expense (Income) 41 40 814 1478 525
Other Operating Expenses, Total 15704 15901 16081 26608 27302
Operating Income 3577 4326 2698 2140 3490
Interest Income (Expense), Net Non-Operating -657 -636 -602 -608 -586
Other, Net 50 45 49 38 42
Net Income Before Taxes 2970 3735 2145 1570 2946
Net Income After Taxes 2224 2791 1587 1296 2313
Minority Interest -1 -8 11 10 -1
Net Income Before Extra. Items 2223 2783 1598 1306 2312
Net Income 2223 2783 1598 1306 2312
Income Available to Common Excl. Extra. Items 2223 2783 1598 1306 2312
Income Available to Common Incl. Extra. Items 2223 2783 1598 1306 2312
Diluted Net Income 2223 2783 1598 1306 2312
Diluted Weighted Average Shares 1322 1327 1329 1338 1328
Diluted EPS Excluding Extraordinary Items 1.68154 2.09721 1.20241 0.97608 1.74096
Dividends per Share - Common Stock Primary Issue 0.5 0.5 0.5 0.5 0.55
Diluted Normalized EPS 1.70477 2.08539 1.65557 1.88793 2.05135
Total Extraordinary Items 0
  • Annual
  • Quarterly
2016 2017 2018 2019 2020 2021
Total Current Assets 31042 31229 45243 50302 56369 60008
Cash and Short Term Investments 3458 1807 6581 8056 10854 12525
Cash & Equivalents 3371 1696 4059 5683 7854 9408
Short Term Investments 87 111 2522 2373 3000 3117
Total Receivables, Net 12164 13181 17631 19617 21742 24431
Accounts Receivable - Trade, Net 12164 13181 17631 17236 7101 7932
Total Inventory 14760 15296 16450 17516 18496 17760
Other Current Assets, Total 660 945 4581 5113 5277 5292
Total Assets 94462 95131 196456 222449 230715 232999
Property/Plant/Equipment, Total - Net 10175 10292 11349 32904 33335 32018
Property/Plant/Equipment, Total - Gross 22802 24290 26869 49794 52035 52672
Accumulated Depreciation, Total -12627 -13998 -15520 -16890 -18700 -20654
Goodwill, Net 38249 38451 78678 79749 79552 79121
Intangibles, Net 13511 13630 36524 33121 31142 29026
Other Long Term Assets, Total 1485 1529 8930 9059 9505 9801
Total Current Liabilities 26250 30648 44009 53303 62017 67807
Accounts Payable 17397 19218 26437 30972 34869 38682
Accrued Expenses 6937 6609 10711 13656 15810 19229
Notes Payable/Short Term Debt 1874 1276 720 0 0 0
Current Port. of LT Debt/Capital Leases 42 3545 1265 3781 5440 4205
Total Liabilities 57632 57440 138231 158585 161326 157924
Total Long Term Debt 25615 22181 71444 64699 59207 51971
Long Term Debt 25615 22181 71444 63918 58157 50721
Deferred Income Tax 4214 2996 7677 7294 6794 6270
Minority Interest 4 4 318 306 312 306
Other Liabilities, Total 1549 1611 14783 32983 32996 31570
Total Equity 36830 37691 58225 63864 69389 75075
Preferred Stock - Non Redeemable, Net 0 0 0 0 0 0
Common Stock 17 17 45440 45972 46513 47377
Additional Paid-In Capital 31618 32079
Retained Earnings (Accumulated Deficit) 38983 43556 40911 45108 49640 54906
Treasury Stock - Common -33483 -37796 -28228 -28235 -28178 -28173
Other Equity, Total -305 -165 5 245 200 187
Total Liabilities & Shareholders’ Equity 94462 95131 196456 222449 230715 232999
Total Common Shares Outstanding 1061 1014 1295 1302 1310 1322
Long Term Investments 15732 17314 20812 23025
Other Current Liabilities, Total 4876 4894 5898 5691
Unrealized Gain (Loss) 97 774 1214 778
Capital Lease Obligations 781 1050 1250
Total Preferred Shares Outstanding 0 0
Mar 2021 Jun 2021 Sep 2021 Dec 2021 Mar 2022
Total Current Assets 55719 56559 60842 60008 61483
Cash and Short Term Investments 8788 10125 12841 12525 11342
Cash & Equivalents 5598 7119 9826 9408 8442
Short Term Investments 3190 3006 3015 3117 2900
Total Receivables, Net 23855 24164 25283 24431 26451
Accounts Receivable - Trade, Net 18304 18976 8398 7932 8728
Total Inventory 17618 16979 17399 17760 18160
Other Current Assets, Total 5458 5291 5319 5292 5530
Total Assets 229606 231164 234891 232999 232873
Property/Plant/Equipment, Total - Net 33153 33140 33233 32018 31645
Goodwill, Net 79552 79552 79121 79121 79060
Intangibles, Net 30639 30080 29545 29026 28543
Long Term Investments 21025 22136 22370 23025 22595
Other Long Term Assets, Total 9518 9697 9780 9801 9547
Total Current Liabilities 60104 59311 64709 67807 69780
Accounts Payable 35358 36691 39468 38682 41570
Accrued Expenses 16018 16539 17871 19229 18388
Notes Payable/Short Term Debt 252 0 0 0 0
Current Port. of LT Debt/Capital Leases 2422 60 1561 4205 4217
Other Current Liabilities, Total 6054 6021 5809 5691 5605
Total Liabilities 158756 157920 160583 157924 159043
Total Long Term Debt 59270 59294 56832 51971 52063
Long Term Debt 59270 59294 56832 51971 52063
Deferred Income Tax 6610 6557 6329 6270 5829
Minority Interest 314 321 310 306 310
Other Liabilities, Total 32458 32437 32403 31570 31061
Total Equity 70850 73244 74308 75075 73830
Preferred Stock - Non Redeemable, Net 0 0 0 0 0
Common Stock 46727 46995 47133 47377 47677
Retained Earnings (Accumulated Deficit) 51203 53331 54264 54906 56488
Treasury Stock - Common -28102 -28252 -28166 -28173 -30145
Unrealized Gain (Loss) 828 977 904 778 -377
Other Equity, Total 194 193 173 187 187
Total Liabilities & Shareholders’ Equity 229606 231164 234891 232999 232873
Total Common Shares Outstanding 1313 1318 1321 1322 1306
  • Annual
  • Quarterly
2016 2017 2018 2019 2020 2021
Cash From Operating Activities 10141 8007 8865 12848 15865 18265
Cash Receipts 172310 176594 186519 248393 264327 284219
Cash Payments -142511 -146469 -148821 -149655 -158636 -165783
Cash Taxes Paid -3060 -2909 -2383 -2717 -2929 -3195
Cash Interest Paid -1140 -1072 -2803 -2954 -2904 -2469
Changes in Working Capital -15458 -18137 -23647 -80219 -83993 -94507
Cash From Investing Activities -2470 -2877 -43285 -3339 -5534 -5261
Capital Expenditures -2224 -1918 -2037 -2457 -2437 -2520
Other Investing Cash Flow Items, Total -246 -959 -41248 -882 -3097 -2741
Cash From Financing Activities -6761 -6751 36819 -7654 -7696 -11356
Financing Cash Flow Items -142 -72 350 59 337 -13
Total Cash Dividends Paid -1840 -2049 -2038 -2603 -2624 -2625
Issuance (Retirement) of Stock, Net -4165 -4032 242 210 264 549
Issuance (Retirement) of Debt, Net -614 -598 38265 -5320 -5673 -9267
Foreign Exchange Effects 2 1 -4
Net Change in Cash 912 -1620 2395 1855 2635 1648
Mar 2021 Jun 2021 Sep 2021 Dec 2021 Mar 2022
Cash From Operating Activities 2892 8739 14260 18265 3563
Cash Receipts 66487 136621 209104 284219 74192
Cash Payments -39171 -79316 -122129 -165783 -44365
Cash Taxes Paid -44 -1552 -2397 -3195 -96
Cash Interest Paid -876 -1263 -2095 -2469 -782
Changes in Working Capital -23504 -45751 -68223 -94507 -25386
Cash From Investing Activities -1867 -2974 -3821 -5261 -1993
Capital Expenditures -829 -1315 -1923 -2520 -1082
Other Investing Cash Flow Items, Total -1038 -1659 -1898 -2741 -911
Cash From Financing Activities -3185 -6558 -8525 -11356 -2650
Financing Cash Flow Items 56 -159 -164 -13 -211
Total Cash Dividends Paid -656 -1306 -1965 -2625 -722
Issuance (Retirement) of Stock, Net 212 330 440 549 -1703
Issuance (Retirement) of Debt, Net -2797 -5423 -6836 -9267 -14
Net Change in Cash -2160 -793 1914 1648 -1080
Investor Name Investor Type Percent Outstanding Shares Held Shares change Holdings Date Turnover Rating
The Vanguard Group, Inc. Investment Advisor/Hedge Fund 8.7762 115316851 1721829 2022-09-30 LOW
Capital World Investors Investment Advisor 4.6346 60896763 2060715 2022-09-30 LOW
BlackRock Institutional Trust Company, N.A. Investment Advisor 4.586 60258711 234645 2022-09-30 LOW
State Street Global Advisors (US) Investment Advisor/Hedge Fund 4.4403 58344728 -339582 2022-09-30 LOW
Capital International Investors Investment Advisor 1.9717 25907490 -351533 2022-09-30 LOW
Geode Capital Management, L.L.C. Investment Advisor/Hedge Fund 1.7789 23374421 186288 2022-09-30 LOW
Morgan Stanley Smith Barney LLC Investment Advisor 1.6592 21801147 696280 2022-09-30 LOW
JP Morgan Asset Management Investment Advisor 1.5392 20224681 368634 2022-09-30 LOW
BofA Global Research (US) Research Firm 1.1617 15264714 80812 2022-09-30 LOW
Dodge & Cox Investment Advisor/Hedge Fund 1.0254 13472772 -236945 2022-09-30 LOW
Invesco Advisers, Inc. Investment Advisor 0.9993 13129851 -500609 2022-09-30 LOW
Norges Bank Investment Management (NBIM) Sovereign Wealth Fund 0.9936 13055500 -67996 2021-12-31 LOW
Charles Schwab Investment Management, Inc. Investment Advisor 0.9056 11899729 224538 2022-09-30 LOW
Columbia Threadneedle Investments (US) Investment Advisor/Hedge Fund 0.7675 10085134 -130262 2022-09-30 LOW
Legal & General Investment Management Ltd. Investment Advisor/Hedge Fund 0.7495 9847659 -473501 2022-09-30 LOW
Dimensional Fund Advisors, L.P. Investment Advisor/Hedge Fund 0.726 9539067 -771778 2022-09-30 LOW
Fidelity Management & Research Company LLC Investment Advisor 0.7187 9443400 -8279 2022-09-30 LOW
BlackRock Investment Management (UK) Ltd. Investment Advisor/Hedge Fund 0.6884 9045542 -197163 2022-09-30 LOW
Northern Trust Investments, Inc. Investment Advisor/Hedge Fund 0.673 8843195 -63183 2022-09-30 LOW
Nordea Funds Oy Investment Advisor 0.6619 8697324 -983166 2022-09-30 LOW

Why choose Capital.com? Our numbers speak for themselves.

Capital.com Group
+500000+

Traders

93000+

Active clients monthly

$57000000+

Monthly investing volume

$31000000+

Withdrawn each month

Trading calculator

Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).

Trade commission
0
  • 1:1
  • 2:1
  • 5:1
  • 10:1
  • 20:1
Leverage
20:1
  • 20
  • 100
  • 500
  • 1000
  • 10000
Investment
Trade size (Leverage x Investement):
Open

Close

Short Long

CVS Company profile

CVS Health (CVS) is an American health service provider headquartered in Woonsocket, Rhode Island. 

In 1963, brothers Stanley and Sidney Goldstein, and Ralph Hoagland founded the company in Lowell, Massachusetts. The first CVS store sold health and beauty products. CVS stands for Consumer Value Stores.

CVS Health has four business segments: Health Care Benefits, Pharmacy Services, Retail/LTC and Corporate/Other.

The Health Care Benefits segment offers traditional, voluntary and consumer-directed health insurance products and related services, including medical, pharmacy, dental, MedicareAdvantage and health information. The segment serves around 35 million customers, including employer groups, individuals, college students, part-time and hourly workers, health care providers, government-sponsored plans, labour groups and expatriates.

The Pharmacy Services segment provides pharmacy benefit management (PBM) solutions, including, plan design offerings and administration, formulary management, retail pharmacy network management services, mail order pharmacy, clinical services and disease management services. The segment’s customers include employers, insurance companies, unions, government employee groups, health plans, plans offered on insurance exchanges and other sponsors of health benefit plans.

The Retail/LTC segment sells prescription drugs, health and wellness products, and general merchandise. It also provides health care services through its MinuteClinic walk-in medical clinics, medical diagnostic testing, and administers vaccinations for illnesses such as influenza and Covid-19. 

Long-term care pharmacy operations are also part of the segment. They distribute prescription pharmaceuticals as well as provide pharmacy consulting and other ancillary services to care homes and other care settings.

As of 31 December 2021, the Retail/LTC segment operated more than 9,900 locations, nearly 1,200 MinuteClinic locations, online services, LTC pharmacies and on-site pharmacies. CVS Health announced in November 2021 that it plans to close 900 stores in the next three years as part of its strategy to overhaul its retail business. The closures will start in spring 2022.

The company dispensed about 26.4% of all retail pharmacy prescriptions in the US in 2021. 

The Corporate/Other segment provides management and administrative expenses to support the Company’s overall operations. It also offers products for which the company no longer solicits or accepts new customers such as large case pensions and long-term care insurance products.

The company’s shares are traded on the New York Stock Exchange under the ticker symbol CVS.

Industry: Healthcare Facilities & Services (NEC)

1 Cvs Dr
WOONSOCKET
RHODE ISLAND 02895-6146
US

Income Statement

  • Annual
  • Quarterly

People also watch

XRP/USD

0.40 Price
-0.730% 1D Chg, %
Long position overnight fee -0.0500%
Short position overnight fee 0.0140%
Overnight fee time 22:00 (UTC)
Spread 0.00386

BTC/USD

22,960.85 Price
-1.110% 1D Chg, %
Long position overnight fee -0.0500%
Short position overnight fee 0.0140%
Overnight fee time 22:00 (UTC)
Spread 60.00

US100

12,514.80 Price
-1.460% 1D Chg, %
Long position overnight fee -0.0192%
Short position overnight fee 0.0077%
Overnight fee time 22:00 (UTC)
Spread 3.0

Oil - Crude

78.66 Price
+1.160% 1D Chg, %
Long position overnight fee -0.0163%
Short position overnight fee 0.0021%
Overnight fee time 22:00 (UTC)
Spread 0.03

Still looking for a broker you can trust?

Join the 500.000+ traders worldwide that chose to trade with Capital.com

1. Create & verify your account 2. Make your first deposit 3. You’re all set. Start trading